{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:20:37Z","timestamp":1762431637102,"version":"3.40.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.brainres.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T13:00:48Z","timestamp":1549371648000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Bone-marrow mononuclear cell therapy in a mouse model of amyotrophic lateral sclerosis: Functional outcomes from different administration routes"],"prefix":"10.1016","volume":"1712","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-7935","authenticated-orcid":false,"given":"Fernanda","family":"Gubert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Bonacossa-Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana B.","family":"Decotelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreia","family":"Vasconcelos-dos-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosalia","family":"Mendez-Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo F.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2019.02.003_b0005","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/brain\/awr074","article-title":"Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis","volume":"134","author":"Beers","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.02.003_b0010","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/stem.1080","article-title":"Neurotrophic bone marrow cellular nests prevent spinal motoneuron degeneration in amyotrophic lateral sclerosis patients: a pilot safety study","volume":"30","author":"Blanquer","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2019.02.003_b0015","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1093\/brain\/awh273","article-title":"Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues","volume":"127","author":"Corti","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2019.02.003_b0020","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2009.09.094","article-title":"Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats","volume":"1306","author":"de Vasconcelos Dos Santos","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.02.003_b0025","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1212\/WNL.47.6_Suppl_4.233S","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.02.003_b0030","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"Fischer","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2019.02.003_b0035","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3109\/14653249.2011.592521","article-title":"Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis","volume":"13","author":"Forostyak","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.brainres.2019.02.003_b0040","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/stem.1812","article-title":"Intrathecal delivery of mesenchymal stromal cells protects the structure of altered perineuronal nets in SOD1 rats and amends the course of ALS","volume":"32","author":"Forostyak","year":"2014","journal-title":"Stem Cells"},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2019.02.003_b0045","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.3727\/096368912X612512","article-title":"Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke","volume":"21","author":"Friedrich","year":"2012","journal-title":"Cell Transplant."},{"key":"10.1016\/j.brainres.2019.02.003_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002494","article-title":"Human umbilical cord blood treatment in a mouse model of ALS: optimization of cell dose","volume":"3","author":"Garbuzova-Davis","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.02.003_b0055","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1523\/JNEUROSCI.2315-06.2006","article-title":"Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS","volume":"26","author":"Gould","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2019.02.003_b0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.scr.2012.11.009","article-title":"Bone-marrow cell therapy induces differentiation of radial glia-like cells and rescues the number of oligodendrocyte progenitors in the subventricular zone after global cerebral ischemia","volume":"10","author":"Gubert","year":"2013","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.brainres.2019.02.003_b0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13287-016-0293-4","article-title":"Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Gubert","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.brainres.2019.02.003_b0070","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM199412223312516","article-title":"Transgenic-mouse model of amyotrophic lateral sclerosis","volume":"331","author":"Gurney","year":"1994","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.brainres.2019.02.003_b0075","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00702-007-0748-y","article-title":"Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: limited intraparenchymal migration and survival narrows therapeutic effects","volume":"114","author":"Habisch","year":"2007","journal-title":"J. Neural. Transm. (Vienna)."},{"key":"10.1016\/j.brainres.2019.02.003_b0080","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","article-title":"Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis","volume":"67","author":"Karussis","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2019.02.003_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2012.09.031","article-title":"Clinical experience with stem cells and other cell therapies in neurological diseases","volume":"324","author":"Karussis","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2019.02.003_b0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2009.10.074","article-title":"Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice","volume":"468","author":"Kim","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2019.02.003_b0095","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/stem.1770","article-title":"Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis: an investigator-initiated trial and in vivo study","volume":"32","author":"Kim","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.brainres.2019.02.003_b0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-444-59544-7.00005-6","article-title":"Bone marrow stem cells in experimental stroke","volume":"201","author":"Kocsis","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.brainres.2019.02.003_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/scrt421","article-title":"Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis","volume":"5","author":"Lewis","year":"2014","journal-title":"Stem. Cell Res. Ther."},{"key":"10.1016\/j.brainres.2019.02.003_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0110722","article-title":"Distribution of mesenchymal stem cells and effects on neuronal survival and axon regeneration after optic nerve crush and cell therapy","volume":"9","author":"Mesentier-Louro","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2019.02.003_b0115","doi-asserted-by":"crossref","first-page":"5078619","DOI":"10.1155\/2016\/5078619","article-title":"Bone marrow-derived cells as a therapeutic approach to optic nerve diseases","volume":"2016","author":"Mesentier-Louro","year":"2016","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.brainres.2019.02.003_b0120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2014.00252","article-title":"ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease","volume":"8","author":"Moloney","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2019.02.003_b0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1471-4892(02)00169-8","article-title":"Therapies in amyotrophic lateral sclerosis-beyond riluzole","volume":"2","author":"Morrison","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.brainres.2019.02.003_b0130","doi-asserted-by":"crossref","first-page":"590","DOI":"10.5966\/sctm.2014-0212","article-title":"Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis","volume":"4","author":"Oh","year":"2015","journal-title":"Stem. Cells Transl. Med."},{"key":"10.1016\/j.brainres.2019.02.003_b0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12015-011-9295-x","article-title":"Comparative effects between bone marrow and mesenchymal stem cell transplantation in GDNF expression and motor function recovery in a motorneuron degenerative mouse model","volume":"8","author":"Pastor","year":"2012","journal-title":"Stem. Cell Rev."},{"key":"10.1016\/j.brainres.2019.02.003_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2013.05.024","article-title":"Bone-marrow mononuclear cells reduce neurodegeneration in hippocampal CA1 layer after transient global ischemia in rats","volume":"1522","author":"Ramos","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2019.02.003_b0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2019.02.003_b0150","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/scd.2013.0089","article-title":"The rise of cell therapy trials for stroke: review of published and registered studies","volume":"22","author":"Rosado-de-Castro","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.brainres.2019.02.003_b0155","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2019.02.003_b0160","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s10517-015-3017-3","article-title":"The use of autologous mesenchymal stem cells for cell therapy of patients with amyotrophic lateral sclerosis in belarus","volume":"159","author":"Rushkevich","year":"2015","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.brainres.2019.02.003_b0165","first-page":"50","article-title":"The effect of autologous bone marrow mononuclear cell transplantation on the survival duration in Amyotrophic Lateral Sclerosis - a retrospective controlled study","volume":"4","author":"Sharma","year":"2015","journal-title":"Am J Stem Cells."},{"key":"10.1016\/j.brainres.2019.02.003_b0170","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/glia.20331","article-title":"Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis","volume":"53","author":"Solomon","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2019.02.003_b0175","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000003359","article-title":"Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS","volume":"87","author":"Staff","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2019.02.003_b0180","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/mt.2008.197","article-title":"Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.brainres.2019.02.003_b0185","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3727\/096368916X693716","article-title":"Transplantation of mesenchymal stromal cells in patients with amyotrophic lateral sclerosis: results of phase I\/IIa clinical trial","volume":"26","author":"Sykova","year":"2017","journal-title":"Cell Transplant."},{"issue":"Suppl 1","key":"10.1016\/j.brainres.2019.02.003_b0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/21678421.2013.778554","article-title":"Mechanisms, models and biomarkers in amyotrophic lateral sclerosis","volume":"14","author":"Turner","year":"2013","journal-title":"Amyotroph. Lateral Scler Frontotemporal Degener."},{"key":"10.1016\/j.brainres.2019.02.003_b0195","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.brainres.2019.02.003_b0200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.2119\/molmed.2011.00498","article-title":"Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis","volume":"18","author":"Uccelli","year":"2012","journal-title":"Mol. Med."},{"key":"10.1016\/j.brainres.2019.02.003_b0205","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neulet.2016.09.030","article-title":"Transplantation of bone marrow mononuclear cells prolongs survival, delays disease onset and progression and mitigates neuronal loss in pre-symptomatic, but not symptomatic ALS mice","volume":"633","author":"Venturin","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2019.02.003_b0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","article-title":"Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Vercelli","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2019.02.003_b0215","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2005-04-1496","article-title":"Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy","volume":"106","author":"Zappia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.brainres.2019.02.003_b0220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3727\/096368910X524764","article-title":"Bone marrow mononuclear cells increase retinal ganglion cell survival and axon regeneration in the adult rat","volume":"20","author":"Zaverucha-do-Valle","year":"2011","journal-title":"Cell Transplant."},{"key":"10.1016\/j.brainres.2019.02.003_b0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/14653240902806986","article-title":"Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"11","author":"Zhang","year":"2009","journal-title":"Cytotherapy"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689931930071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689931930071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T20:04:06Z","timestamp":1554753846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689931930071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":45,"alternative-id":["S000689931930071X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2019.02.003","relation":{},"ISSN":["0006-8993"],"issn-type":[{"type":"print","value":"0006-8993"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone-marrow mononuclear cell therapy in a mouse model of amyotrophic lateral sclerosis: Functional outcomes from different administration routes","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}